Hyperfine (HYPR) Free Cash Flow Growth (5y) (2026)

Hyperfine (HYPR) Free Cash Flow Growth (5y) (2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	200.36 Bn	194.75 Bn	7.27 Bn
2	Stryker	129.99 Bn	126.52 Bn	4.50 Bn
3	Medtronic	120.03 Bn	110.81 Bn	6.41 Bn
4	Boston Scientific	74.30 Bn	73.76 Bn	3.85 Bn
5	Edwards Lifesciences	52.61 Bn	48.36 Bn	1.35 Bn
6	Dexcom	34.71 Bn	32.76 Bn	830.00 Mn
7	GE HealthCare Technologies	34.24 Bn	32.13 Bn	2.18 Bn
8	Koninklijke Philips	26.46 Bn	23.14 Bn	4.55 Bn
9	Steris	23.30 Bn	22.81 Bn	684.20 Mn
10	Hyperfine	90.65 Mn	45.88 Mn	1.98 Mn

Download Data

Date	Value
Jun 30, 2026	9.65%
Mar 31, 2026	-3.77%